Zydus Lifesciences

Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha’, in India to treat multiple cancers

Read more

Zydus Lifesciences signs licensing deal with Formycon

Read more

Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules

Read more

Zydus receives NMPA approval in China for Venlafaxine extended-release capsules

Read more

IPA announces leadership transition

Read more

Zydus, Pinkathon come together for breast cancer awareness in India

Read more

Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern Hemisphere 2025-26

Read more

Zydus Lifesciences receives Health Canada approval for smoking cessation drug

Read more

Zydus gains tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg

Read more

Panel Discussion: Beyond the needle: Innovations in painless drug delivery

Read more